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SUMMARY – Patients with urolithiasis, particularly hypercalciuria, may have reduced bone min-
eral density (BMD). There are numerous risk factors contributing to reduction of BMD such as ad-
vanced age, sedentary lifestyle, smoking, low calcium intake, etc. The aim of our study was to investi-
gate the association of lifestyle risk factors and daily intake of milk and dairy products with determi-
nants of BMD in a group of recurrent calcium stone formers (RSF) compared with healthy subjects 
(HS). The study was carried out at the Department of Mineral Research, Faculty of Medicine in 
Osijek, Croatia. The study included 144 subjects, i.e. 56 RSF and 78 HS. BMD was assessed by dual-
energy x-ray absorptiometry. A standard self-reported questionnaire was used to collect data on life-
style risk factors. Current dietary intake was assessed by personal interview that included questions 
about milk and dairy product intake. Low BMD was observed in 44.64% of RSF and 35.90% of HS. 
RSF consumed significantly less milk and dairy products than HS. Calcium restriction in dietary 
recommendations might be unnecessary due to the impact on bone mineral loss in RSF and dual-
energy x-ray absorptiometry should be included in the routine evaluation of RSF.
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Introduction
Urolithiasis remains a common health, social and 
economic problem of modern society and occurs at 
least once in life in 15% of Caucasian men and 6% of 
women1,2, with a recurrence rate of around 50% over 
10 years and 75% over 15 and 20 years, respectively3,4. 
Recurrent urolithiasis is defined as three or more epi-
sodes of kidney stones in a 5-year period5. The preva-
lence of urolithiasis has increased in recent decades in 
both males and females6. Calcium oxalate and calcium 
phosphate are the most common types of kidney 
stones, accounting for >80% of stones7. Idiopathic hy-
percalciuria is the most prevalent abnormality in cal-
cium kidney stone formers; metabolic analyses per-
formed in these patients yielded a rate of hypercalci-
uria of 60%8. In practice, hypercalciuria is defined as 
daily calcium excretion of over 250 mg/day in women 
and 300 mg/day in men9.
The association between urolithiasis and bone min-
eral density (BMD) is already known and according to 
several clinical and epidemiological studies performed 
in recurrent calcium stone formers (RSF), patients 
with urolithiasis, particularly hypercalciuria, may have 
reduced bone density. Bone loss in these patients is 
caused by increased resorption and/or decreased bone 
formation10-13.
Dietary habits and lifestyle play an important role 
in the formation of kidney stones, as well as in BMD.
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The aim of our study was to investigate the associa-
tion of age, anthropometric parameters and lifestyle 
factors with determinants of BMD in a group of RSF 
compared with healthy subjects (HS).
Material and Methods
Subjects
We investigated 56 unrelated patients with recur-
rent urinary stone formation who consecutively visited 
the Department of Urology, Osijek University Hospi-
tal Centre. The diagnosis of recurrent urolithiasis was 
based on the history of two or more episodes of renal 
colic, radiographic evidence of stones and report of 
stone analysis, and only patients with confirmed cal-
cium oxalate urolithiasis were included in the study.
Control group consisted of 78 patients without a 
known history of renal stone disease and with ultra-
sound confirmation of the absence of kidney stones 
who were undergoing osteoporosis evaluation at the 
Department of Mineral Research, Faculty of Medicine 
in Osijek. The following subjects were excluded: sub-
jects with gastrointestinal diseases (ulcerative colitis, 
malabsorption syndrome, chronic pancreatitis), renal 
tubular acidosis, pregnant women, subjects with pri-
mary hyperparathyroidism and other diseases affecting 
calcium metabolism (hyperthyroidism, acromegaly, 
sarcoidosis, diabetes or cancer), and those using medi-
cations such as corticosteroids, barbiturates, estrogen, 
calcium or vitamin D. A written informed consent was 
obtained from all participants and the study was 
 approved by the Ethics Committee of the Faculty of 
Medicine, Osijek, Croatia.
Anthropometric measurements
Body weight and height were measured with sub-
jects wearing light clothing and no shoes. Body mass 
index (BMI) was calculated as weight (kg) divided by 
squared height (m²); BMI >30 kg/m2 was used as a 
parameter for obesity and BMI >24.9 kg/m2 as excess 
weight14.
Lifestyle risk factors
Data on lifestyle (smoking status, current physical 
activity, sports activity in the past) were collected by 
use of standard self-reported questionnaire. The ques-
tions regarding sports activity in the past included spe-
cific questions about frequency and duration of previ-
ous sports activities (in hours) on a weekly basis (per-
forming regular exercise for more than 30 minutes two 
times a week). Current physical activities (walking, 
biking, manual work, etc.) were classified into three 
levels, as follows: very active (≥4.5 hours per week), 
moderately active (1.5-4.5 hours per week), and less 
active (<1.5 hours per week).
Smoking habit was categorized as current, past or 
never used. Current dietary intake was assessed by per-
sonal interview that included questions about milk 
and dietary product intake. Answers were classified 
into three groups, as follows: never or less than once a 
day, once a day, and more than once a day.
Bone density measurement
Bone mineral density and bone mineral content 
(BMC) were assessed by dual-energy x-ray absorpti-
ometry (Lunar Prodigy, GE Healthcare, USA). BMD 
and BMC measurements were performed at lumbar 
spine and femoral neck. Areal BMD was expressed in 
g/cm2 and standard deviation from the young normal 
mean (T-score) based on the World Health Organiza-
tion (WHO) criteria. A score from -1 to -2.5 SD be-
low the norm indicates low bone mass or osteopenia, 
and a score of equal or more than -2.5 SD below the 
norm indicates osteoporosis14.
Statistical analysis
Categorical data were presented as absolute and 
relative frequencies, and numerical data as mean with 
standard deviation or median with interquartile range. 
Differences between categories were tested with χ2-
test and comparison between groups was done with 
the independent samples T-test or Mann-Whitney U 
Test. Statistical analyses were conducted using SAS 
software (version 8.02, SAS Institute Inc., Cary, NC, 
USA) with the level of statistical significance set at 
p<0.05.
Results
Clinical characteristics of RSF and HS groups are 
presented in Table 1.
The RSF group included 51.79% of men and 
48.21% of women; there was no statistically significant 
difference according to age or sex between RSF and HS 
groups. However, RSF had higher BMI (27.56 kg/m2; 
interquartile range 25.27 kg/m2 to 29.73 kg/m2) com-
pared to HS (26.81 kg/m2; interquartile range 23.92 
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BMD was lower in RSF at all measured sites but with-
out statistical significance (Table 2).
A significant difference was obtained for more than 
once daily milk consumption between RSF (14.29%) 
and HS (21.79%) (χ2-test, p=0.017). Smoking habit, 
current physical activity, previous sports activity and 
level of education did not differ significantly between 
the two groups (Table 3).
Discussion
We investigated the influence of lifestyle factors on 
BMD in RSF. Although kidney stones are more com-
Table 1. Age and anthropometric parameter distribution  
of recurrent stone formers (RSF) and healthy subjects (HS)
RSF (n=56) HS (n=78) p
Age (yrs)
mean±SD 49.16±11.59 52.51±7.73 0.116
Height (cm)
mean±SD 170.91±9.66 167.64±6.81 0.030
Weight (kg)









Independent samples T-test; *Mann-Whitney U test
Table 2. Distribution of T scores, bone mineral density 
(BMD) and bone mineral contents (BMC) for lumbar 
spine and femoral neck in recurrent stone formers (RSF) 
and healthy subjects (HS)










































Independent samples T-test; *Mann-Whitney U test
Table 3. Demographic and lifestyle risk factors in 
recurrent stone formers (RSF) and healthy subjects (HS)
RSF n (%) HS n (%) p
Age group (yrs):
≤60 47 (83.93) 67 (85.90)
>60 9 (16.07) 11 (14.10) 0.752
Body mass index:
≤24.9 13 (23.22) 27 (34.62)
25.0-29.9 32 (57.14) 34 (43.59)
≤30.0 11 (19.64) 17 (21.79) 0.258
Smoking:
Current smoker 16 (28.57) 28 (35.90)
Past smoker 13 (23.22) 18 (23.08)
Never smoked 27 (48.21) 32 (41.03) 0.633
Current physical activity:
Very active  3 (5.36) 10 (12.82)
Moderately active 39 (69.64) 49 (62.82)
Less active 14 (25.00) 19 (24.36) 0.349
Previous sports activity:
Yes 27 (48.21) 30 (38.46)
No 29 (51.79) 48 (61.54) 0.260
Milk consumption:
Never/less than 
once a day 31 (55.36) 24 (30.77)
Once a day 17 (30.35) 37 (47.43)
More than once a 
day 8 (14.29) 17 (21.79) 0.017
Educational level:
Elementary 
school 10 (17.86) 14 (17.95)
High school 29 (51.79) 31 (39.74)
University 17 (30.35) 33 (42.31) 0.316
Total 56 (100.00) 78 (100.00)
χ2-test
kg/m2 to 29.73 kg/m2) (Mann-Whitney U test, 
p=0.283).
Low BMD was observed in 44.64% of RSF (osteo-
porosis 20%) and 35.90% of HS (osteoporosis 10.71%). 
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mon in men than in women, male predominance was 
not confirmed in our study. However, in our study RSF 
had a significantly higher body weight than HS and 
this finding is consistent with previous studies15.
Recent evidence shows that an increase in body 
weight and BMI is associated with the increasing risk 
of urolithiasis. Weight gain from early adulthood was 
associated with an increased risk of kidney stones in 
both men and women15. Studies in patients with uroli-
thiasis showed higher BMI to be significantly associ-
ated with lower urinary pH level16-18. The reasons for 
progressive decline in urine pH with increasing BMI 
in urolithiasis patients have not been defined yet. Obe-
sity is associated with insulin resistance and hyperin-
sulinemia, metabolic disorders known to have a strong 
influence on urine composition, thus increasing the 
kidney fractional excretion of calcium, uric acid and 
oxalate, resulting in lower urinary pH16,19,20. A high 
animal protein diet results in subtle metabolic acidosis 
and potentially could lead to increased bone turnover. 
Metabolic acidosis caused by the high protein diet in-
duces the release of bone calcium to buffer acid load, 
consequently leading to hypercalciuria and bone loss21.
On the other hand, decreased bone mass in pa-
tients with urolithiasis was demonstrated in several 
clinical and epidemiological studies22-25.
In our study, a significant bone loss in patients with 
urolithiasis was confirmed by the rate of osteoporosis 
of 20% and 10.71% in the RSF and HS group, respec-
tively.
In their study performed using dual-energy x-ray 
absorptiometry, Trinchieri et al. found that BMD was 
lower in hypercalciuric patients (57%) than in nor-
mocalciuric patients (44%), while the rate of osteope-
nia and osteoporosis in hypercalciuric patients was 48 
and 6%, respectively26. In their study that included 
normocalciuric patients with recurrent calcium stones, 
Tugcu et al. found BMD to be decreased in 76.7% and 
20.0% of patients and healthy subjects, respectively10. 
In a follow up study, Cvijetic et al. also found greater 
BMD reduction in stone formers as compared with 
controls27.
Milk and dairy products are primary sources of cal-
cium and have an impact on bone density28,29. Accord-
ing to our results, HS consumed significantly more milk 
and dairy products than RSF. These findings are inter-
esting and intriguing because a calcium restricted diet 
which is often recommended in urolithiasis patients 
might increase bone resorption leading to bone loss30,31.
However, reduction of calcium supply increases 
oxalate absorption and enhances urinary saturation 
with oxalate salts, which might explain why low-cal-
cium diet increases the risk of calcium oxalate stone 
formation32. This point has been supported by another 
study where stone-formers reported reduced dietary 
calcium intakes when factored for body weight but 
urinary calcium excretion was comparable between 
the two groups suggesting that stone formers were 
in more negative calcium balance compared to non- 
-stone-formers33.
Borghi et al. found that in men with recurrent cal-
cium oxalate stones and hypercalciuria, low animal 
protein and salt diet in combination with normal cal-
cium intake had a protective effect in the prevention of 
stone recurrence34. Similar results were obtained by 
other research groups35,36. Therefore, obesity and low 
calcium diet in RSF might explain the high rate of 
decreased BMD in our study as well.
On the other hand, in our study, smoking habit, 
physical activity and level of education were not sig-
nificantly different between RSF and HS. These data 
are concordant with the findings of several research 
groups which do not support the possible association 
between smoking and urinary tract stones37,38.
However, there are research groups that might ar-
gue these findings since their data claim that cigarette 
smoking may induce urolithiasis by decreasing urinary 
flow and increasing serum cadmium in healthy sub-
jects39,40. Also, there are some reports suggesting that 
adult smokers had twice the odds of having urinary 
stones (OR 2.1, 95% CI 1.1-4.0) as compared with 
age-matched non-stone formers41. In contrast, ciga-
rette smoking is associated with low BMD and in-
creased risk of fracture in both genders42,43. Although 
the underlying mechanisms of the association between 
smoking and low BMD are not completely known, 
this could be attributed to the adverse effect of smok-
ing on skeletal remodeling and bone cells44, decreased 
intestinal calcium absorption due to smoking45, and its 
impact on sex hormones46. There are limited literature 
data on the impact of physical activity on the forma-
tion of kidney stones but the importance of physical 
activity in the prevention of many chronic diseases is 
well known47,48.
In a study that included 84,225 postmenopausal 
women, Sorensen et al. found that physical activity 
might reduce the risk of incident kidney stones. They 
found that the intensity of the activity was not impor-
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tant because only mild to moderate weekly activity was 
enough to be protective against kidney stone forma-
tion49. These results are in contrast to a recent study 
that examined the association between physical activ-
ity and incidence of kidney stones. In this prospective 
cohort study, age-adjusted and multivariate-adjusted 
analyses failed to confirm significant associations be-
tween physical activity and kidney stones50. Although 
physical inactivity appears to be a risk factor for kidney 
stones, the pathogenetic mechanisms remain elusive 
and need to be further investigated.
Gur et al. report on a significant correlation be-
tween educational level and BMD. In their study, the 
prevalence of osteoporosis showed an inverse relation-
ship with the level of education, ranging from 18.6% 
for high educated to 34.4% for low educated women51. 
Although the mechanisms of association between ed-
ucational level and low BMD remain partly unex-
plained, the higher BMD values in the highest educa-
tion group may be attributed to sufficient calcium in-
take.
Our study had several limitations. Daily fluid, salt 
and protein intakes as important factors for stone dis-
ease were not assessed. An additional limitation of the 
study may be that the questionnaire used provided 
limited information on the quantity of calcium intake, 
as well as on precise physical activities of our partici-
pants. These limitations should be taken into account 
on interpreting the study results.
These results suggested that patients with recurrent 
calcium stones had greater BMD decline compared to 
patients without lithiasis. The most important predic-
tors of BMD in our study were body weight and dairy 
intake. Therefore, BMD analyses should be included 
in the routine evaluation of RSF. However, calcium re-
striction in dietary recommendations might be unnec-
essary due to the impact on bone mineral loss in RSF.
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Sažetak
RIZIČNI ČIMBENICI I KOŠTANA MASA U BOLESNIKA S RECIDIVIRAJUĆOM UROLITIJAZOM:  
PRESJEČNO ISTRAŽIVANJE NA 144 ISPITANIKA
I. Marić, T. Kizivat, M. Smolić, R. Smolić, T. Opačak-Bernardi, K. Šolić, H. Roguljić,  
J. Milas Ahić, A. Tucak i I. Mihaljević
Bolesnici s urolitijazom, osobito oni s hiperkalciurijom, imaju smanjenu koštanu mineralnu gustoću (bone mineral density, 
BMD). Rizični čimbenici gubitka koštane mase su uznapredovala dob, sjedilački način života, pušenje i smanjen unos kal cija. 
Cilj našeg istraživanja bio je ustanoviti povezanost rizičnih čimbenika i dnevnog unosa mlijeka i mliječnih prerađevina s 
odrednicama BMD u bolesnika s recidivirajućom kalcijskom urolitijazom te ih usporediti sa zdravim ispitanicima. Istraživa-
nje je provedeno na Zavodu za mineralni metabolizam Medicinskog fakulteta u Osijeku. U istraživanju su sudjelovala 144 
ispitanika, od čega 56 bolesnika s recidivirajućom kalcijskom urolitijazom i 78 zdravih ispitanika. BMD je određen metodom 
dvoenergetske apsorpciometrije X zraka (DXA). Podatci o čimbenicima rizika dobiveni su anketnim upitnikom, a unos  hrane 
je ocijenjen osobnim intervjuom koji je uključivao pitanja o unosu mlijeka i mliječnih proizvoda. Snižen BMD zabilježen je 
u 44,64% bolesnika s recidivirajućom urolitijazom i u 35,90% zdravih ispitanika. Bolesnici s recidivirajućom urolitijazom 
konzumirali su znatno manje mlijeka i mliječnih proizvoda u odnosu na zdrave ispitanike. Nepotrebna je preporuka smanje-
nog unosa kalcija bolesnicima s recidivirajućom urolitijazom zbog utjecaja na gubitak koštane mase, a DXA treba biti dio 
rutinske procjene bolesnika s recidivirajućom urolitijazom.
Ključne riječi: urolitijaza; mineralna gustoća kosti; tjelesna težina; indeks tjelesne mase; tjelesna aktivnost; pušenje; unos kalcija
